Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well I don't like to bug the company with stupid stuff too much but I asked him a question they answered So here for all you saying they're selling shares.
Hi,
Thank you for your interest in Sunshine Biopharma, we value our shareholders and we do our utmost to protect them. Please rest assured that the company does not sell shares on the open market and neither the management. You can always check that in the Quarterly reports. The company is fully compliant with the SEC reporting.
Take Care,
The Administration
Whoever it is for whatever reason will not let this thing run month after month same exact thing
I think market reacts after November 3rd one way or another to SBFM. Unless we get some awesome news before then but most people are watching and waiting till after election
Great news things are progressing quickly
Company SBFM also sent me the pod cast email and a link in there reply back to me
We should be holding 10 cents minimum right now with all that's happening here now. but the market knows we got a real product and there making sure they keep this one down I think until announcement of vitro and mice testing is cleared then I don't think they can hold it down anymore after that then I think they'll finely let it go up to where the stock belongs.
This is crazy we're going the wrong way
Hopefully meaning we're getting another PR. That's an old press release that was under the two million dollar loan PR but now the dates been changed and it's up at the top something's up
What a joke two cents come on
Had to make a call to SBFM this morning and here's what I got.
Keep smiling be positive we know what we got.
If that isn't the best call on a Monday morning I don't know what is.
150,000 share pre-market
More news out we ain't playing today
That 8K was really nice news confirms our deal with the University of Georgia on a partnership. Won't be able to hold SBFM down too much longer guarantee you. The university has a lot of contacts with big pharma and don't think for a second the University of Georgia don't want their out there as the ones who found an awesome cure for covid-19. $$$$$
Nice news out today
We all know here in the next week to 4 weeks time sbfm will be heading north bound how high will we go we'll see I'm locked and loaded Good luck to you all. I'm still hoping for that 20 to 30 cent range
Sunshine Biopharma's Adva-27a Is 16-times More Effective At Killing Multidrug Resistant Breast Cancer Cells
Written by undefined on Invalid date
Sunshine Biopharma Inc. (OTCBB: SBFM), a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer
, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line. Cytotoxicity studies measure the ability of a drug to destroy cancer cells in vitro. The results of the study showed that Adva-27a is 16-times more effective at killing Multidrug Resistant Breast Cancer cells than Etoposide, the current commonly used drug. In addition, data generated by the study revealed that Adva-27a is unaffected by the molecular machinery which are responsible for making cancer cells resistant to drugs.
"These findings are remarkable", said Dr. Steve N. Slilaty, Sunshine's President and CEO. He added, "Cancer cells become resistant to anti-tumour drugs by overproducing a protein called P-Glycoprotein. Encoded by the ABCB1 gene (also called the MDR1 gene), P-Glycoprotein is a trans-membrane enzyme that binds and transports drugs to the outside of cancer cells thereby making them resistant. P-Glycoprotein pumps out most, if not all, antineoplastics including doxorubicin, vinblastine, gemcitabine, etoposide, paclitaxel, etc. Our data showed that P-Glycoprotein cannot bind and transport Adva-27a. This is extremely interesting with far reaching scientific and drug development implications. Previously unavailable, Adva-27a now offers a chemical structure which can be used as a basis for studying the mechanism of action of P-Glycoprotein as well as for the development of new drugs which can overcome the resistance caused by P-Glycoprotein and similar enzymes".
I have to agree with all of you this thing is primed for a major lift off should see 7 to 10 cents without news with news look out.
Sunshine Biopharma is also developing its flagship anti-cancer compound called Adva-27a which is meant to destroy multidrug resistant cancer cells, including pancreatic cancer cells, small-cell lung cancer cells, breast cancer cells and uterine sarcoma cells. The mechanism by which Adva-27a is able to destroy cancer cells is through the inhibition of a key cell-cycle enzyme called Topoisomerase II. With thorough research, Sunshine Biopharma is running several clinical trials to curb these life-threatening diseases and the company is looked by the major pharmaceuticals of the world.
Currently, there are no drugs that can effectively arrest replication of the virus in people who have contracted the illness. On May 22, 2020, Sunshine Biopharma filed a provisional patent application for a library of molecules that were designed to inhibit the coronavirus proteases, thus shutting down the ability of the virus to multiply and cause illness. As part of its land grant tripartite mission, the University of Georgia is committed to creating and applying new knowledge for the public good. UGA’s Center for Drug Discovery, as well as the Colleges of Pharmacy, are excited to be a part of this ground-breaking research related to the discovery of new treatment options for COVID-19.
Scientists at the at the University of Georgia have opened a new path to developing COVID-19 drugs. They showed that a set of small molecules can block the activity of protein inside SARS-CoV-2. The protein, PLpro, is known to be essential in the replication of the virus.
I believe we're really close and this time we go way past that $0.07 mark we hit a couple months ago
I also found it
I emailed the link to the company and told him it was an awesome read.So if it did leak we should hear something really soon. No matter what I believe we're off to the races real soon here this looks like it's going to go soon. first stop back over that $0.07 mark we hit a couple months ago and heading way north from there I believe.
Game changer about to happen
Hoping for a big week
Sure would be this could be the week will see
I've been here since April and I haven't sold a single share. I have averaged up since my entry and I'll admit that I was getting a little discouraged here too. But I'm not willing to sell at $0.02 when I didn't sell it at about $0.07 a few months ago and something's lining up here I'd like the company to talk and explain a little more but I think it's worth giving it a couple more months to figure out what they got and what we're sitting on good luck to you brother on whatever you decide but I'll ride this one out.
I believe we're going to see another PR this month and I'm going to bet there's a lot of people chasing the next one. Been here so long I just got that feeling.
Ridiculous to me that we're sitting at under .02 a share. While other covid stocks with test strips no FDA approval no nothing face masks and other ppe crap are sitting at 5 plus a share lol what a joke
So 3 to 4 cents tomorrow sounds good to me
Well we did find out one thing today Georgia University believes in their compound or they wouldn't have took it on.
Nice news this morning
If there is a one-two punch coming I'm thinking it could be one release on covid one release on cancer that I think will be the one two punch coming our way. We shall see 2 million loan was mentioned for cancer and for covid-19 I believe.
I was hoping for tomorrow but you could be right. All I know is volume has picked up even if the price is going down it's because they're just trying to buy low for the next run whatever it is it's coming soon this week or next
$0.10 sounds good to me too hopefully by the end of this month
Seems to me every time the price goes down everybody starts emailing the company and then they finally put out news. So maybe the company needs a whole lot of emails every single day asking for news
With another million bought at close seems like someone's stocking up for the next news should it be this week
I wonder who that million could be the whale trying to get back in for the next ride
Sounds like loan company wants their $0.30 a share value and is waiting to get it. News this week would be perfect
That's exactly right it's because of President testing positive covid stocks will get more attention next week. Now if company release the news next week If you should be on for a heck of a ride